These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2577106)
81. [Potential antineoplastics, 6. Synthesis of hexestrol derivatives with alkylating side chains]. Hamacher H; Mangold C Arch Pharm (Weinheim); 1983; 316(3):271-81. PubMed ID: 6305306 [No Abstract] [Full Text] [Related]
82. [Effect of various pharmacologic agents on the nucleus and chromosomes of human lymphocytes]. Bastide P; de Rocca Serra MF; Fellmann N; Jaffray JY; Geneix A; Malet P; Turchini JP Cytologia (Tokyo); 1981 Jun; 46(1-2):387-91. PubMed ID: 7273862 [No Abstract] [Full Text] [Related]
83. Cytotoxicity and induction of sister chromatid exchanges in human and rodent brain tumor cells treated with alkylating chemotherapeutic agents. Tokuda K; Bodell WJ Cancer Res; 1988 Jun; 48(11):3100-5. PubMed ID: 2835151 [TBL] [Abstract][Full Text] [Related]
84. Targeting the endothelin axis in human melanoma: combination of endothelin receptor antagonism and alkylating agents. Berger Y; Bernasconi CC; Juillerat-Jeanneret L Exp Biol Med (Maywood); 2006 Jun; 231(6):1111-9. PubMed ID: 16741059 [TBL] [Abstract][Full Text] [Related]
85. Sites in nucleic acids reacting with alkylating agents of differing carcinogenicity of mutagenicity. Singer B J Toxicol Environ Health; 1977 Jul; 2(6):1279-95. PubMed ID: 328918 [TBL] [Abstract][Full Text] [Related]
86. Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin. Calsou P; Salles B Cancer Chemother Pharmacol; 1993; 32(2):85-9. PubMed ID: 8485812 [No Abstract] [Full Text] [Related]
87. [Method for the primary selection of active antitumor alkylating preparations in vitro and in vivo]. Montsevichiute-Eringene EV Vopr Onkol; 1975; 21(10):73-7. PubMed ID: 1189354 [TBL] [Abstract][Full Text] [Related]
88. Bombesin receptor antagonists. 5 new irreversible alkylating analogues. de Castiglione R; Gozzini L; Galantino M; Corradi F; Ciomei M; Roletto F; Bertolero F Farmaco; 1992 Jun; 47(6):855-67. PubMed ID: 1326977 [TBL] [Abstract][Full Text] [Related]
89. [Effect of antibiotics on nucleic acids and nucleic acid metabolism]. Kersten W; Kersten H; Wanke H; Ogilvie A Zentralbl Bakteriol Orig; 1970; 212(2):259-65. PubMed ID: 4986320 [No Abstract] [Full Text] [Related]
90. The interaction of cancer chemotherapy agents with mononuclear phagocytes. Mantovani A Adv Pharmacol Chemother; 1982; 19():35-66. PubMed ID: 6762072 [No Abstract] [Full Text] [Related]
91. Increase of glycogen and oligosaccharide contents in ascites tumor cells under the influence of alkylating agents. Tashiro T; Sakurai Y Gan; 1969 Aug; 60(4):465-8. PubMed ID: 4310237 [No Abstract] [Full Text] [Related]
92. DNA strand damage induced by anticancer agents and its repair in relation to their mode of action in leukemic cells. Nakamura T; Sasada M; Tatsumi K Nihon Ketsueki Gakkai Zasshi; 1977 Dec; 40(6):1131-44. PubMed ID: 565120 [No Abstract] [Full Text] [Related]
93. Comparative chemical and biological studies of four prototype phosphoraziridine antineoplastic agents. Dunn JA; Bardos TJ Biochem Pharmacol; 1991 Mar 15-Apr 1; 41(6-7):885-92. PubMed ID: 2009083 [TBL] [Abstract][Full Text] [Related]
94. The development of hypoxic tumor cell cytotoxic agents. Kirkpatrick DL Pharmacol Ther; 1989; 40(3):383-99. PubMed ID: 2646652 [No Abstract] [Full Text] [Related]